SEC Form 4 · accession 0000921895-16-003164
DIGIRAD CORP · DRAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond William Vogel
Officer — CEO of DMS Health Technologies
Period of report
Feb 1, 2016
Accepted (ET)
Feb 3, 2016 · 4:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000707388
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $5.12 | Feb 1, 2016 | A | 15,169 | A | — | Feb 1, 2026 | Common Stock | 15,169 | 15,169 | D |
| Restricted Stock UnitF2,F3,F4 | — | Feb 1, 2016 | A | 15,000 | A | — | — | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1These Stock Options are scheduled to vest as to 25% of the options on each of February 1, 2017, February 1, 2018, February 1, 2019 and February 1, 2020, subject to the reporting person continuing to provide service through each such date.
- F2The Reporting Person is the Chief Executive Officer of DMS Health Technologies, Inc., a wholly-owned subsidiary of the Issuer.
- F3Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
- F4The Restricted Stock Units are scheduled to vest as to 25% of the units on each of February 1, 2017, February 1, 2018, February 1, 2019 and February 1, 2020, with vesting of 50% of each such Restricted Stock Unit tranche to be further subject to the satisfaction of certain performance criteria to be determined and approved by the Compensation Committee with respect to each such period.